Dividend News Update: BOTS Board Approves Dividend; BOTS' First Publication Reaches Number One in Five Categories on Amazon's eBook Store; BOTS Reconsiders Developing AI Assistant Based on Scott Adams Mar. 21, 2023 2:37 PM ET Source: BOTS Inc
Tecogen Acquires Service Contracts for 202 Cogeneration Units From Aegis Energy Services, LLC Mar. 20, 2023 9:48 AM ET Source: Tecogen Inc
Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental Dermatology Mar. 20, 2023 8:00 AM ET Source: Timber Pharmaceuticals
E-Cite Receives EPA Approval and is Officially Assigned an EPA Manufacturing Code to Produce Electric Vehicles Mar. 16, 2023 9:47 AM ET Source: VAPORBRANDS INTERNATIONAL, INC.
Can B Corp. Completes Corporate Debt Restructuring to Position for Uplisting to National Securities Exchange Mar. 15, 2023 11:52 AM ET Source: Canbiola Inc.
GeoVax Congratulates Don Diamond, Ph.D. as Finalist for Vaccine Industry Excellence Award at World Vaccine Congress Mar. 15, 2023 9:00 AM ET Source: GeoVax, Inc.
Innovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic Researchers Mar. 15, 2023 8:00 AM ET Source: Innovation Pharmaceuticals Inc
Forian Inc. to Announce Fourth Quarter and Full Year 2022 Results on March 27, 2023 Mar. 14, 2023 11:30 AM ET Source: Forian Inc.
Cavitation Technologies, Inc. Provides Update on the Company's Existing Patented Technology for Use in the Oil and Gas Industry Mar. 14, 2023 9:00 AM ET Source: Cavitation Technologies, Inc
Cannabis Science Conference Returns to Portland, OR, With Renewed Focus on Analytical, Medical, Cultivation, and Psychedelic Scientific Insights Mar. 13, 2023 3:08 PM ET Source: Cannabis Science Conference
GeoVax to Report 2022 Financial Results on Thursday, March 23, 2023 and Provide Corporate Update Mar. 9, 2023 9:00 AM ET Source: GeoVax, Inc.
Wee-Cig International Corporation Initiating Steps to Move From Bench-Top to Commercial Production Mar. 9, 2023 8:00 AM ET Source: Weecig Corp
Epazz Holdings: ZenaDrone AI Predictive Partnered with US Defense Contractor to Submit for SBIR Phase II for ZenaDrone 1000 Mar. 9, 2023 5:00 AM ET Source: Epazz, Inc.
BioCorRx Announced Interim Positive Safety and Pharmacokinetic Results of Phase 1 Clinical Trial at 4th Annual NIH HEAL Initiative Investigator Meeting Mar. 7, 2023 3:18 PM ET Source: BioCorRx Inc
Ascent Solar Technologies, Inc. Announces First Step of Strategic Plan; Executes Term Sheet for Acquisition of Assets From Leading European Thin-Film Solar Manufacturer Mar. 7, 2023 8:00 AM ET Source: Ascent Solar Technologies, Inc
GeoVax to Participate at the 35th Annual Roth Conference Mar. 6, 2023 9:00 AM ET Source: GeoVax, Inc.
Infliximab Market New Innovations and Future Expansion 2023-2031 Mar. 3, 2023 1:23 PM ET Source: Absolute Reports Pvt. Ltd.
Shingles Vaccine Market is Booming in Near Future 2023-2031 Mar. 3, 2023 9:52 AM ET Source: Absolute Reports Pvt. Ltd.
Dr. Robert Lufkin and Dr. Stephen Sideroff Join Forces on Their "Path of Longevity Summit" April 25-May 2nd, Engage Agent Alan Morell for Advisory, Commercial Rights, Products Licensing, Literary and Podcast Feb. 28, 2023 10:30 AM ET Source: Creative Management Partners LLC
GeoVax Vaccine Data Included in HIV-Therapy Presentation at the Conference on Retroviruses and Opportunistic Infections Feb. 27, 2023 9:00 AM ET Source: GeoVax, Inc.
Timber Pharmaceuticals Receives European Orphan Drug Designation for TMB-001 in X-Linked Recessive Ichthyosis Feb. 24, 2023 8:00 AM ET Source: Timber Pharmaceuticals
Dais's Nanotechnology Addresses Critical Market Needs Generated by New Regulatory Activity Seeking Tighter PFAS Contamination Removal and Potential Ban of PFAS Containing Components (HVAC Refrigerants) Feb. 23, 2023 8:30 AM ET Source: Dais Analytic Corporation
BioLife Sciences, Inc. (OTC:PK BLFE) (BioLife or the Company) is Pleased to Announce the Release of the Prototype of the Company's Copper-Infused Microfiber Towels for Q2 of the Fiscal Year Feb. 23, 2023 8:30 AM ET Source: BioLife Sciences, Inc
ABVC BioPharma Receives Australian TGA Approval to Initiate Phase II Study of Vitargus (R) Feb. 21, 2023 8:30 AM ET Source: ABVC BioPharma, Inc.
